A2M is well presented at ISPOR 19th Annual European Congress, 29 October - 2 November 2016, Vienna, Austria with the following presentations by Dr. Mark Nuijten covering standard cost-effectiveness analyses, nutritioneconomics and financial valuation for medical innovatiion.
UK COST-EFFECTIVENESS ANALYSIS FOR MANAGEMENT OF CMV DISEASE IN PATIENTS POST ALLOGENEIC STEM CELL TRANSPLANTATION WITH A NOVEL ADOPTIVE T CELL THERAPY
EVALUATION OF METHODOLOGICAL VARIATIONS IN THE EVENT SIMULATION APPROACHES OF PUBLISHED HEALTH ECONOMIC MODELS IN OBESITY PREVENTION AND THERAPY
FOOD FOR THOUGHT (BUT NOT TOO MUCH) FOR HEALTH ECONOMIC ANALYSES OF NUTRITIONAL INTERVENTIONS IN OBESITY
ECONOMIC VALUATION OF ULTRA-INNOVATIVE DRUGS FROM A BROADER PERSPECTIVE